| Medtronic, Inc. (MDT) |
|
|
| NYSE:MDT |
Last Trade: Today @ 4:15:08 PM |
| Last Price: 36.10 |
Change: ($-0.35 -0.9603%) |
| Open: |
36.68 |
Prev. Close: |
36.45 |
| Day's High: |
36.78 |
Low: |
36.00 |
| 52-Week High: |
57.99 |
52-Week Low: |
44.26 |
| Bid: |
36.10 / 100 |
Ask: |
36.19 / 200 |
| Volume: |
6,230,613 |
Outstanding: |
1,130,658,726 |
| Market cap: |
$55 B
|
|
|
|
|
| Medtronic is a provider of enhanced products and therapies for use by medical professionals to address the healthcare needs of their patients. Co.'s primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose, and throat conditions. As of Apr 27 2007, Co. operated in eight operating segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal and Navigation, Vascular, Neurological, Diabetes, Cardiac Surgery, Ear, Nose, and Throat as well as Physio-Control. |
Medtronic, Inc. Press ReleasesStudy Shows Practice Improvement Program Enhances Guideline-Recommended Device and Drug Therapy Use - Monday, July 26, 2010
New Data in the New England Journal of Medicine Show Medtronic Deep Brain Stimulation Provides Susta - Wednesday, June 02, 2010
New Medtronic Data Shows Health Care Utilization Differs by Type of Implantable Defibrillator Therap - Saturday, May 15, 2010
Medtronic to Appeal Jury Verdict in U.S. Patent Case Involving CoreValve® Transcatheter Aortic Valve - Friday, April 02, 2010
Medtronic Receives FDA Panel’s Unanimous Recommendation for Approval of Revo MRI™ SureScan™ Pacing S - Friday, March 19, 2010
Medtronic’s Endeavor Stent Continues to Demonstrate Compelling and Consistent Long-Term Clinical Res - Sunday, March 14, 2010
Medtronic Announces Public Offering of Senior Notes - Thursday, March 11, 2010
Physio Control reprend les expéditions inconditionnelles de ses défibrillateurs LIFEPAK(R) à l'échel - Thursday, March 04, 2010
German Appeals Court Says CoreValve Devices From Medtronic Do Not Infringe Edwards Lifesciences’ And - Thursday, February 11, 2010
Pivotal Study of Medtronic Deep Brain Stimulation Therapy Shows Long-Term Reduction in Seizure Rate - Sunday, December 06, 2009
Medtronic-Sponsored Study Indicates Bi-Ventricular Pacing Superior to Right Ventricular Pacing in Av - Sunday, November 15, 2009
Medtronic to Announce Financial Results for Its Second Fiscal Quarter - Tuesday, November 10, 2009
Medtronic Expects New Data on Drug-Eluting Stents and Transcatheter Heart Valves to Feature at TCT 2 - Friday, September 18, 2009
New REVERSE Analysis Reinforces Improvements Seen in Mild Heart Failure Patients with Cardiac Resync - Sunday, August 30, 2009
Thrombus Aspiration with Medtronic’s Export Catheter May Improve Outcomes for Heart Attack Patients - Saturday, March 28, 2009
Medtronic’s Endeavor Stent Shows Consistent and Sustained Safety and Effectiveness Benefits at Two Y - Saturday, March 28, 2009
Largest Study on Balloon Kyphoplasty Demonstrates Superior Benefits Compared to Non-Surgical Care in - Wednesday, February 25, 2009
Medtronic and Boston Scientific Reach Agreement on Patent Cases - Tuesday, January 27, 2009
Medtronic to Acquire Ablation Frontiers - Monday, January 12, 2009
Medtronic CEO William Hawkins to Speak at 27th Annual JP Morgan Healthcare Conference - Friday, January 09, 2009
Study in the Journal of the American Medical Association Shows Medtronic Deep Brain Stimulation Ther - Tuesday, January 06, 2009
Medtronic to Participate in the JP Morgan Healthcare Conference - Tuesday, December 30, 2008
Medtronic Acquires Influent Medical's Repose Product Line - Wednesday, December 24, 2008
Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Medtronic - Friday, December 12, 2008
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Medtronic, Inc. - Friday, December 12, 2008
Bernstein Litowitz Berger & Grossmann LLP Announces Filing of Securities Class Action Against Medtro - Wednesday, December 10, 2008
Medtronic Announces Key Activities at American Heart Association Scientific Sessions 2008 - Friday, November 07, 2008
Court Order Dissolves Rapid Exchange Injunction on October 29, 2008 - Wednesday, October 22, 2008
Danish Study Supports Efficacy of Endeavor(R) Stent - Thursday, October 16, 2008
Medtronic's Third-Generation Endeavor(R) Resolute Drug-Eluting Stent Maintains Strong Efficacy and S - Sunday, October 12, 2008
New Data on Medtronic's ENDEAVOR(R) Drug-Eluting Coronary Stent Shows Strong Performance in Complex - Sunday, October 12, 2008
Medtronic Announces Plans to Release Data on Broad Portfolio of Cardiovascular Innovations at TCT 20 - Friday, October 10, 2008
Medtronic "Recovering" From 2007 Defibrillator Wire Recall and Eyes Opportunities Worldwide, an Indu - Monday, September 29, 2008
FDA Classifies as a Class I Action an Urgent Medical Device Correction by Physio-Control - Thursday, September 11, 2008
Evidence Supports Utility of Remote Patient Management and Fluid Monitoring Alerts to Potentially Re - Tuesday, September 02, 2008
Initial Data Presented on World's First Pacemaker Designed for Safe Use in MRI Machines - Monday, September 01, 2008
Medtronic to Participate in the Goldman Sachs Health Care Conference - Friday, June 06, 2008
Medtronic Awarded $250 Million Damages in Patent Case against Boston Scientific - Wednesday, May 28, 2008
Major Sudden Cardiac Arrest Risk Stratification Trials Unveiled - Thursday, May 15, 2008
Thrombus Aspiration before Stenting Benefits Patients Suffering Myocardial Infarction, Study Shows - Tuesday, May 13, 2008
Medtronic Anticipates 'Practice-Changing' Clinical Data for Interventional Cardiologists at EuroPCR - Monday, May 12, 2008
Medtronic Initiates Voluntary Field Actions for Selected Heparin-Coated Products Used During Cardiop - Thursday, May 08, 2008
Get this stock quote and other market data from XML Stock Quotes.com
|
